ArticleIUBMB life2026

MMP9 Knockout by CRISPR-Cas9 Reduces Bladder Cancer Malignancy But Does Not Synergize With BCG and Anti-PD-L1 in an Orthotopic Mouse Model.

Juliana Alves de Camargo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.